NASDAQ:TNYA

Tenaya Therapeutics Stock Forecast

etoro logo Buy TNYA
*Your capital is at risk
$0.727
+0.0010 (+0.138%)
At Close: Aug 07, 2026

Should you buy TNYA stock?

Last updated:

Based on market data through , StockInvest.us rates Tenaya Therapeutics, Inc. (TNYA) as a Strong Sell Candidate with a technical score of -5.20 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Up 0.14%
  • 3-month trend forecast Down 9.18%
  • Strong Sell Candidate -5.20
AI Analysis AI Analysis of TNYA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TNYA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Green day on Friday for Tenaya Therapeutics, Inc. stock after gaining 0.138%
(Market data through Aug 07, 2026)

Sell candidate since Aug 06, 2026 Gain 0.14%

The Tenaya Therapeutics, Inc. stock price gained 0.138% on the last trading day (Friday, 7th Aug 2026), rising from $0.726 to $0.727. During the last trading day the stock fluctuated 4.28% from a day low at $0.725 to a day high of $0.756. The price has fallen in 6 of the last 10 days and is down by -6.22% for this period. Volume fell on the last day by -1 million shares and in total, 2 million shares were bought and sold for approximately $1.15 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.18% during the next 3 months and, with a 90% probability hold a price between $0.570 and $0.81 at the end of this 3-month period.

TNYA Signals & Forecast

There are few to no technical positive signals at the moment. The Tenaya Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.743 and $0.781. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -21.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Tenaya Therapeutics, Inc. stock

Tenaya Therapeutics, Inc. finds support from accumulated volume at $0.710 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0310 between high and low, or 4.28%. For the last week the stock has had daily average volatility of 6.70%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TNYA) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Tenaya Therapeutics, Inc. to open at $0.736, and during the day (based on 14 day Average True Range), to move between $0.701 and $0.753, which gives a possible trading interval of +/-$0.0518 (+/-7.39%) up or down from last closing price. If Tenaya Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.710 (2.31%) than the resistance at $0.790 (8.70%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Tenaya Therapeutics, Inc. will release earnings BMO on Wednesday, August 12, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.0800. We will update the financials statements for Tenaya Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.56% in the first trading day after earnings release.

Is Tenaya Therapeutics, Inc. stock A Buy?

Tenaya Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.200 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $0.736 ( 1.26%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TNYA Performance

Trading levels for TNYA

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.767 5.52%
R2 0.755 3.89%
R1 0.748 2.89%
Price 0.727
S1 0.724 -0.373%
S2 0.717 -1.38%
S3 0.705 -3.01%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.87 19.07%
R2 0.86 17.96%
R1 0.790 8.70%
Price 0.727
S1 0.710 -2.31%
S2 0.686 -5.56%
S3 0.680 -6.44%

FAQ

What is the symbol for Tenaya Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Tenaya Therapeutics, Inc. is TNYA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tenaya Therapeutics, Inc. Stock?
Based on market data through Aug 07, 2026, StockInvest.us rates Tenaya Therapeutics, Inc. (TNYA) as a Strong Sell Candidate with a technical score of -5.20 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Aug 06, 2026, the price has risen 0.14%. The current 3-month trend forecast projects a fall of 9.18%.

How to buy Tenaya Therapeutics, Inc. Stock?
Tenaya Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tenaya Therapeutics, Inc. Stock.

What's the current price of Tenaya Therapeutics, Inc. Stock?
As of the end of day on the Aug 07, 2026, the price of an Tenaya Therapeutics, Inc. (TNYA) share was $0.727.

What is the 52-week high and low for Tenaya Therapeutics, Inc. Stock?
The 52-week high for Tenaya Therapeutics, Inc. Stock is $2.35 and the 52-week low is $0.532.

What is the market capitalization of Tenaya Therapeutics, Inc. Stock?
As of the Aug 07, 2026, the market capitalization of Tenaya Therapeutics, Inc. is 157.715M.

When is the next earnings date for Tenaya Therapeutics, Inc.?
The upcoming earnings date for Tenaya Therapeutics, Inc. is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT TENAYA THERAPEUTICS, INC.
Tenaya Therapeutics
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mut...
GOLDEN STAR
Ticker Change Signal Date
MHO
$150.54
0.96% Aug 05
JEF
$55.71
1.63% Aug 04
FCX
$62.63
11.16% Jul 31
BIIB
$202.19
2.84% Jul 24
S
SW
$43.71
10.46% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE